About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Psychiatry, Mental Health and Addictions Research Group at the Vall d'Hebron Research Institute is a multidisciplinary team that over the past 13 years has focused its scientific activity on the research (both nationally and internationally) of clinical, therapeutic and etiopathogenic aspects of:
At international level, it participates and/or coordinates several European projects of great repercussion in the area of mental health. At national level, it is part of the CIBERSAM (Centre for Biomedical Research in Mental Health Network) together with other leading groups, conducting research of excellence.
PMID: 33831461 Journal: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS Year: 2021 Reference: Neurosci Biobehav Rev. 2021 Jul;126:529-541. doi: 10.1016/j.neubiorev.2021.03.034. Epub 2021 Apr 5. Impact factor: 8.989 Publication type: Review in international publication Authors: Anmella, Gerard, Fico, Giovanna, Lotfaliany, Mojtaba, Hidalgo-Mazzei, Diego, Soto-Angona, Oscar, Gimenez, Anna, Amoretti, Silavia, Murru, Andrea, Radua, Joaquim, Solanes, Aleix et al. DOI: 10.1016/j.neubiorev.2021.03.034
PMID: 31550967 Journal: Journal of Attention Disorders Year: 2021 Reference: J Atten Disord. 2021 May;25(7):978-988. doi: 10.1177/1087054719875787. Epub 2019 Sep 24. Impact factor: 3.256 Publication type: Paper in international publication Authors: Martinez-Luna, Nieves, Daigre, Constanza, Palma-Alvarez, Felipe, Perea-Ortueta, Marta, Grau-Lopez, Lara, Roncero, Carlos, Castell-Panisello, Eudald, Ramos-Quiroga, Josep Antoni et al. DOI: 10.1177/1087054719875787
PMID: 33773886 Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY Year: 2021 Reference: Eur Neuropsychopharmacol. 2021 Jul;48:89-109. doi: 10.1016/j.euroneuro.2021.02.017. Epub 2021 Mar 24. Impact factor: 4.6 Publication type: Paper in international publication Authors: Garcia-Gonzalez, Sara, Lugo-Marin, Jorge, Setien-Ramos, Imanol, Gisbert-Gustemps, Laura, Arteaga-Henriquez, Gara, Diez-Villoria, Emiliano, Ramos-Quiroga, Josep Antoni et al. DOI: 10.1016/j.euroneuro.2021.02.017
PMID: 32917399 Journal: JOURNAL OF PSYCHIATRIC RESEARCH Year: 2021 Reference: J Psychiatr Res. 2021 Apr;136:474-482. doi: 10.1016/j.jpsychires.2020.07.044. Epub 2020 Aug 2. Impact factor: 4.791 Publication type: Paper in international publication Authors: Pineda-Cirera, Laura, Cabana-Dominguez, Judit, Grau-Lopez, Lara, Daigre, Constanza, Sanchez-Mora, Cristina, Palma-Alvarez, Raul Felipe, Ramos-Quiroga, Josep Antoni, Ribases, Marta, Cormand, Bru, Fernandez-Castillo, Noelia et al. DOI: 10.1016/j.jpsychires.2020.07.044
The doctoral training program of excellence led by the UAB TOUCH MSCA-COFUND, focused on the field of mental health, opens its second call until March 31.
Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.
These results reinforce the need for more individualized attention to address educational needs from an early stage.
